August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Liso-cel is a feasible and effective option for patients with R/R large B cell lymphoma – MD Anderson Cancer Center
Dec 11, 2024, 09:53

Liso-cel is a feasible and effective option for patients with R/R large B cell lymphoma – MD Anderson Cancer Center

MD Anderson Cancer Center shared a post on X:

“For patients with relapsed or refractory large B cell lymphoma and secondary central nervous system involvement, Lisocabtagene Maraleucel (liso-cel) is a feasible and effective option, our Dr. Sairah Ahmed reported at ASH24 this morning.”

Liso-cel is a feasible and effective option for patients with R/R large B cell lymphoma - MD Anderson Cancer Center

More posts featuring MD Anderson Cancer Center.